Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: DELT1970 who wrote (3862)	3/29/2000 2:37:00 PM
From: Joe	Read Replies (1) \| Respond to of 4140

Well, with respect to SRGL, I think the patent holder of the Surgical Correction of Presbyopia procedure is going to litigate the laser approach. So, with SRGL's procedure in question, I doubt that they will be spending money on the clinicals. I have not looked at the patents so I do not have a feel on the merit of the action. With regard to the use of infrared to shrink collagen as in Sunrise LTK, I am very bullish. No one risking a challange to the Sand Patents held by SNRS. Refractec has an RF approach to the procedure, but they have a long way to go to show that the procedure is even effective, regardless of the press releases coming from the company. FDA approval due for LTK is due within several months. I expect a big product roll out at ASCRS. Joe